Literature DB >> 18348877

The use of hyperbaric oxygen therapy in ophthalmology.

Halit Oguz1, Gungor Sobaci.   

Abstract

Hyperbaric oxygen therapy is a primary or adjuvant therapeutic method used in treatment of various acute or chronic disorders. Currently, eye diseases are among the off-label use of hyperbaric oxygen. However, there is an increasing body of evidence showing its safety and efficacy in retinal artery occlusion, cystoid macular edema secondary to retinal vein occlusion, scleral thinning and necrosis faced after pterygium surgery, orbital rhino-cerebral mucormycosis, nonhealing corneal edema, and anterior segment ischemia. Its potential to treat some blinding disease has also been pointed out in recent studies. This article constitutes an up-to-date summary of knowledge and therapeutic use of hyperbaric oxygen, and aims to contribute understanding of current and potential use of hyperbaric oxygen therapy in ophthalmology.

Entities:  

Mesh:

Year:  2008        PMID: 18348877     DOI: 10.1016/j.survophthal.2007.12.002

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  22 in total

1.  [Guidelines from the DOG, RG and BVA: retinal artery occlusion : November 2016 status].

Authors: 
Journal:  Ophthalmologe       Date:  2017-02       Impact factor: 1.059

2.  Systemic oxygen therapy versus oral enalapril for treatment of diabetic macular ischemia: a randomized controlled trial.

Authors:  Farideh Sharifipour; Mohammadreza Razzaghi; Alireza Ramezani; Mohsen Azarmina; Mehdi Yaseri; Roham Soheilian; Masoud Soheilian
Journal:  Int Ophthalmol       Date:  2015-08-21       Impact factor: 2.031

3.  Hyperoxia therapy of pre-proliferative ischemic retinopathy in a mouse model.

Authors:  Wenbo Zhang; Harumasa Yokota; Zhimin Xu; Subhadra P Narayanan; Lauren Yancey; Akitoshi Yoshida; Dennis M Marcus; Robert W Caldwell; Ruth B Caldwell; Steven E Brooks
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-11       Impact factor: 4.799

Review 4.  Retinal oxygen: from animals to humans.

Authors:  Robert A Linsenmeier; Hao F Zhang
Journal:  Prog Retin Eye Res       Date:  2017-01-18       Impact factor: 21.198

5.  Differential gene expression in mouse retina related to regional differences in vulnerability to hyperoxia.

Authors:  Yuan Zhu; Riccardo Natoli; Krisztina Valter; Jonathan Stone
Journal:  Mol Vis       Date:  2010-04-28       Impact factor: 2.367

6.  Hyperbaric oxygen therapy for the treatment of radiation-induced macular ischemia.

Authors:  Shamim A Haji; Ronald Ep Frenkel
Journal:  Clin Ophthalmol       Date:  2010-05-14

7.  The effect of high-dose steroids, and normobaric oxygen therapy, on recent onset non-arteritic anterior ischemic optic neuropathy: a randomized clinical trial.

Authors:  Mohammad Pakravan; Nasrin Sanjari; Hamed Esfandiari; Parastou Pakravan; Mehdi Yaseri
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-08-10       Impact factor: 3.117

8.  Neuroprotective effect of hyperbaric oxygen therapy on anterior ischemic optic neuropathy.

Authors:  Bat-Chen R Avraham-Lubin; Olga Dratviman-Storobinsky; Shimrit Dadon-Bar El; Murat Hasanreisoglu; Nitza Goldenberg-Cohen
Journal:  Front Neurol       Date:  2011-04-13       Impact factor: 4.003

9.  Rapid reduction of macular edema due to retinal vein occlusion with low-dose normobaric hyperoxia.

Authors:  Jorge G Arroyo; Brendan Seto; Keiko Yamada; Ke Zeng; Robert Minturn; Colin A Lemire
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-02-22       Impact factor: 3.117

10.  Normobaric oxygen therapy for scleral ischemia or melt.

Authors:  Farideh Sharifipour; Mahmoodreza Panahi-Bazaz; Esmaeil Idani; Mohammad Malekahmadi; Sepehr Feizi
Journal:  J Ophthalmic Vis Res       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.